CLS - Company ID 0001030894
The table below shows CELESTICA INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $4.05B | $3.19B | $2.89B | $2.65B | $2.50B | $2.39B |
| Cost of revenue | $3.61B | $2.78B | $2.52B | $2.37B | $2.24B | $2.14B |
| Gross profit | $437.20M | $416.10M | $371.00M | $273.90M | $260.60M | $253.80M |
| R&D | $41.20M | $36.40M | $34.00M | $17.60M | $18.70M | $19.40M |
CELESTICA INC reported annual revenue of $12.39B for fiscal year 2025. That is up 28.5% from $9.65B in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $117.40M | $38.40M | $38.90M | $112.50M | $91.80M | $79.30M |
| Operating income | $272.10M | $325.00M | $272.50M | $128.80M | $138.00M | $132.90M |
| Income tax | $44.00M | $43.10M | $46.30M | $27.50M | $34.50M | $18.50M |
| Net income | $212.30M | $267.80M | $211.00M | $86.20M | $89.50M | $95.00M |
| EPS (diluted) | $1.83 | $2.31 | $1.82 | $0.74 | $0.75 | $0.80 |